骨质疏松症m6A甲基化修饰的研究进展
DOI:
作者:
作者单位:

兰州大学第二医院

作者简介:

通讯作者:

中图分类号:

基金项目:

1.国家自然科学基金(81874017, 81960403,82060405) 2.兰州大学第二医院“萃英科技创新”计划 (CY2021‑MS‑A07)


Advances in m6A methylation modification in osteoporosis
Author:
Affiliation:

lan zhou second hospital

Fund Project:

Fund programs: National Natural Science Foundation of China (81874017,81960403,82060405);"Cuiying Scientific and Technological Innovation" Program of Second Hospital of Lanzhou University (CY2021‑MS‑A07)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    N6-甲基腺苷是一种可逆的转录后修饰,在所有真核生物的生命活动中起着重要的调节作用。近年来,研究发现甲基化通过调控RNA的稳定、翻译效率等关键基因,对骨发育和骨稳态进行调节。在这篇综述中,我们总结了目前m6A甲基化及其相关调节因子在骨代谢和骨质疏松中的功能作用,以及m6A甲基化相关调控因子作为潜在治疗靶点的重要进展。这些发现将为m6A甲基化在骨质疏松症中的深入研究提供新的方向和认识,也为骨质疏松症的药物治疗提供了新的策略。

    Abstract:

    N6-methyladenosine (m6A) is a reversible post-transcriptional modification that plays an important regulatory role in the life activities of all eukaryotes. In recent years, m6A methylation has been found to regulate bone development and bone homeostasis by modulating key genes such as RNA stabilization and translation efficiency. In this review, we summarize the current functional roles of m6A methylation and its related regulators in bone metabolism and osteoporosis, as well as the important advances of m6A methylation-related regulators as potential therapeutic targets. These findings will provide new directions and insights into the in-depth study of m6A methylation in osteoporosis, as well as new strategies for the pharmacological treatment of osteoporosis.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-09-07
  • 最后修改日期:2023-11-03
  • 录用日期:2024-04-02
  • 在线发布日期:
  • 出版日期: